Cambridge, Canada Clinical Trials

A listing of Cambridge, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6 clinical trials
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency

The primary objective of this study is to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo in the treatment of participants in heart failure with a reduced ejection fraction and with iron deficiency

natriuretic peptide
ejection fraction
nt-probnp
nesiritide
cardiac resynchronization therapy
Cambridge Cardiac Care Center
 (1.3 away) Contact site
  • 5316 views
  • 22 Jul, 2021
  • +365 other locations
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity

The researchers are doing the study to see if semaglutide may reduce the risk of having cardiovascular events in patients with overweight or obesity and with prior cardiovascular disease. The participant will either get semaglutide (active medicine) or placebo ("dummy" medicine). Which treatment the participants get is decided by chance. …

cardiovascular disease
overweight or obesity
body mass index
Novo Nordisk Investigational Site
 (1.3 away) Contact site
  • 7712 views
  • 18 Jul, 2021
  • +1164 other locations
Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation

The purpose of the ANT-006 study is to evaluate the bleeding profile of abelacimab relative to rivaroxaban in patients with atrial fibrillation (AF) at moderate-to-high risk of stroke.

aspirin
stroke
atrial flutter
rivaroxaban
fibrillation
Anthos Investigative Site
 (1.6 away) Contact site
  • 0 views
  • 25 Jul, 2021
  • +52 other locations
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

This is a study in adults who had a heart attack (myocardial infarction). The purpose of this study is to find out whether a medicine called empagliflozin helps to lower the chances of having to go to the hospital for heart failure and whether it lowers the chances of dying …

revascularisation
myocardial infarction
diabetes
acute myocardial infarction
angiography
Cambridge Cardiac Care Inc.
 (1.3 away) Contact site
  • 0 views
  • 19 Jul, 2021
  • +148 other locations
A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight

This study is open to adults, aged 18 to 75 years, with overweight or obesity. People with body mass index (BMI) of 27 or higher to join the study. People who have diabetes cannot participate. The purpose of this study is to find out whether a medicine called BI 456906 …

diabetes
body mass index
overweight or obesity
Joanne F Liutkus Medicine Professional Corporation
 (0.0 away) Contact site
  • 0 views
  • 18 Jul, 2021
  • +38 other locations
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

cardiovascular disease
hemoglobin a1c
body mass index
Cambridge Cardiac Care Centre
 (1.3 away) Contact site
  • 593 views
  • 25 Jul, 2021
  • +888 other locations